TelyRx Holdings Inc.
TELY.TO
TSX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 35.49% | 16.02% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 35.49% | 16.02% | |||
| Cost of Revenue | 114.63% | -36.96% | |||
| Gross Profit | 4.30% | 73.52% | |||
| SG&A Expenses | 2.00% | 99.98% | |||
| Depreciation & Amortization | -36.52% | 154.49% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.20% | 28.82% | |||
| Operating Income | -3.18% | -195.36% | |||
| Income Before Tax | -51.77% | -190.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -50.89% | -192.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -50.89% | -192.63% | |||
| EBIT | -3.18% | -195.36% | |||
| EBITDA | -3.00% | -199.12% | |||
| EPS Basic | -43.15% | -192.53% | |||
| Normalized Basic EPS | 27.14% | -191.11% | |||
| EPS Diluted | -43.10% | -190.00% | |||
| Normalized Diluted EPS | 27.14% | -191.11% | |||
| Average Basic Shares Outstanding | 5.43% | 0.00% | |||
| Average Diluted Shares Outstanding | 5.43% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||